BioSpace News Archive

Genetown

Cerevel Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that members of the management team will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022.

September 6, 2022
·
4 min read
Spexis provides business update and announces financial results for the first half of 2022

Spexis AG announced its financial results for the first half of 2022 and provided a strategic business update.

September 6, 2022
·
9 min read
Business

Frédéric PELONG, Chief Financial Officer, Joins the Valbiotis Board of Directors

Regulatory News: Valbiotis, a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces the appointment of Frédéric PELONG to the Company’s Board of Directors.

September 6, 2022
·
5 min read
Business

Occlutech Announces New Members to the Executive Management Team - Appoints Chief Commercial Officer and Vice President Global Business Development & Marketing

Occlutech Holding AG, one of the world’s leading providers of minimally invasive structural heart disease devices has expanded its Executive Management Team by appointing two new members.

September 6, 2022
·
3 min read
Drug Development

Abivax Phase 2b Study Results of Obefazimod (ABX464) in Ulcerative Colitis Published in the Lancet Gastroenterology & Hepatology

Abivax SA announces that a scientific article has been published in the peer-reviewed journal “The Lancet Gastroenterology & Hepatology”, the world-leading gastroenterology and hepatology research journal.

September 6, 2022
·
10 min read
Drug Development

ITM to Present Trial Design of Ongoing Phase III COMPOSE Study in Advanced Neuroendocrine Tumors at ESMO 2022

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced that a scientific poster on the design of its second phase III clinical trial, COMPOSE, in advanced neuroendocrine tumors will be presented at the upcoming ESMO Congress from September 9-13, 2022, in Paris.

September 6, 2022
·
4 min read
Drug Development

Helixmith Announces Topline Results from Phase 2A Study of Engensis for Treatment of ALS (Amyotrophic Lateral Sclerosis)

Helixmith announced topline results from a Phase 2A study in individuals with ALS. ALS is a fatal neurodegenerative disorder of upper and lower motor neurons that causes progressive paralysis and eventual death due to respiratory failure.

September 6, 2022
·
3 min read
Drug Development

Oculis announces publication and presentation of Phase 2 data showing topical OCS-01 improves macular thickness and visual acuity in patients with diabetic macular edema

Oculis S.A. announces that the Phase 2 DX-211, a randomized, double blinded, multi-center and vehicle controlled clinical trial assessing the safety and efficacy of topical OCS-01 in patients with Diabetic Macular Edema has been published by the Acta Ophthalmologica journal.

September 6, 2022
·
5 min read
Drug Development

Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy

IVERIC bio, Inc. announced positive topline results from GATHER2, the Company’s second Phase 3 clinical trial of Zimura®, a novel investigational complement C5 inhibitor, for the treatment of geographic atrophy.

September 6, 2022
·
14 min read
Drug Development

SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that the Chilean Public Health Institute approved a phase II clinical trial for its inactivated Omicron strain COVID-19 vaccine and trivalent COVID-19 vaccine on August 31st.

September 6, 2022
·
3 min read